Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Preventive Cardiology|November 26, 2015
Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR)Maria Cristina Penaloza-Ramos, Sue Jowett, Jonathan Mant, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 9, 2016
Influence of ethnicity on acceptability of method of blood pressure monitoring: a cross-sectional study in primary careSally Wood, Sheila M Greenfield, M Sayeed Haque, et al.
American Journal of Hypertension|November 16, 2014
Ethnicity and differences between clinic and ambulatory blood pressure measurementsUna Martin, M Sayeed Haque, Sally Wood, et al.
European Journal of Endocrinology|June 13, 2013
The clinical spectrum of RET proto-oncogene mutations in codon 790Hélène Bihan, Arnaud Murat, Marinos Fysekidis, et al.
American Journal of Hypertension|January 23, 2019
Schedules for Self-monitoring Blood Pressure: A Systematic ReviewJames A Hodgkinson, Richard Stevens, Sabrina Grant, et al.
BMC Cardiovascular Disorders|February 15, 2017
Telemonitoring and/or self-monitoring of blood pressure in hypertension (TASMINH4): protocol for a randomised controlled trialMarloes Franssen, Andrew Farmer, Sabrina Grant, et al.
BMC Cardiovascular Disorders|March 26, 2013
Targets and self-management for the control of blood pressure in stroke and at risk groups (TASMIN-SR): protocol for a randomised controlled trialClaire O'Brien, Emma P Bray, Stirling Bryan, et al.
Molecular Vision|April 10, 2007
Three new PAX6 mutations including one causing an unusual ophthalmic phenotype associated with neurodevelopmental abnormalitiesAnouk Dansault, Gabriel David, Claire Schwartz, et al.
JAMA|August 27, 2014
Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trialRichard J McManus, Jonathan Mant, M Sayeed Haque, et al.
Lancet (London, England)|March 4, 2018
Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trialRichard J McManus, Jonathan Mant, Marloes Franssen, et al.
Pageof 3